MedPath

A CLINICAL TRIAL TO STUDY THE EFFECT OF SIDDHA DRUG PAVALA VEERA CHUNNAM IN PATIENTS HAVING CHOLELITHIASIS

Phase 2
Conditions
Health Condition 1: K808- Other cholelithiasis
Registration Number
CTRI/2020/09/027900
Lead Sponsor
Government Siddha Medical College Chennai
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Accidentally identified gall stone in USG

Asymptomatic Cholelithiasis.

Stone Size less than 8mm (normal lumen size is 8mm)

Exclusion Criteria

Pregnant and lactating mothers.

Cholecystitis.

Pancreatitis

Obstructive Jaundice.

Choledo Cholelithiasis

Acute Cholelithiasis

Gall Stone patients with other comorbidities

Malignancy of gall bladder

-Will be excluded clinically or based on available medical reports

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Outcome is mainly assessed by reduction in clinical symptoms measured by reduction in size of gall stones with interpretation of USG abdomen.Timepoint: 48days.
Secondary Outcome Measures
NameTimeMethod
nilTimepoint: nil
© Copyright 2025. All Rights Reserved by MedPath